Celcuity
Nadene has over 20 years of experience working in clinical operations for clinical-stage pharmaceutical and biotechnology companies. She has broad experience in therapeutic areas (oncology, psychiatry, rheumatology & pain, pulmonology, infectious disease, and women’s health). Before joining Celcuity, Nadene held positions of increasing responsibility at Pfizer, Cypress Bioscience, Aragon Pharmaceuticals, and Daré Bioscience, leading to NDA submissions and approvals for milnacipran (Savella®) and apalutimide (ERLEADA®), and XACIATO™, respectively.
Nadene holds a Bachelor of Science Degree in Health Science from San Diego State University and a Master of Science in Clinical Research Administration from George Washington University.
This person is not in any offices
Celcuity
Celcuity is a clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated companion diagnostic (CDx) and therapeutic (Rx) strategy that leverages the CELsignia CDx platform.